@WHO: WHO guidelines recommend that a new class of drugs, called integrase inhibitors, should be used in 1st-line antiretroviral therapy. If the transition to these drugs is delayed, #HIV #DrugResistance will continue to have a high human & financial cost. 👉 https://t.co/5MXEpzdhCf https://t.co/DC2YZwObpc

@WHO: WHO guidelines recommend that a new class of drugs, called integrase inhibitors, should be used in 1st-line antiretroviral therapy. If the transition to these drugs is delayed, #HIV #DrugResistance will continue to have a high human & financial cost. 👉 https://t.co/5MXEpzdhCf https://t.co/DC2YZwObpc

http://twitter.com/WHO
via IFTTT

Comments